These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9133040)

  • 1. [Manifestations of immunopathology and validation of immunotherapy of diabetic retinopathy].
    Zaĭtseva NS; Dudnikova LK; Slepova OS; Li LS; Smirnova NB; Zueva MV; Kalamkarov GR; Shevchenko TF
    Vestn Oftalmol; 1997; 113(1):27-31. PubMed ID: 9133040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic and local immunity in patients with diabetic retinopathy].
    Ekgardt VF; Tarasova LN; Teplova SN; Alekhina TV
    Vestn Oftalmol; 1998; 114(1):46-8. PubMed ID: 9584642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to types II and IV collagens, tumor necrosis factor-alpha and circulating immune complexes in lacrimal fluid and serum of patients with diabetic retinopathy and different stages].
    Balashova LM; Zaĭtseva NS; Teplinskaia LE; Koval'chuk LV; Gankovskaia LV; Obraztsova EN; Aronskind MS
    Vestn Oftalmol; 2000; 116(3):31-4. PubMed ID: 10918849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the body's immunological state and sensitization to eye and insulin antigens in proliferative diabetic retinopathy].
    Degtiarenko TV
    Oftalmol Zh; 1981; 36(2):95-9. PubMed ID: 7015209
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
    Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
    Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could diabetic retinopathy be an autoimmune disease?
    Kastelan S; Zjacić-Rotkvić V; Kastelan Z
    Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinico-immunological validation of a differentiated approach to the use of corticosteroids in treating S-dependent uveoretinitis].
    Slepova OS; Katargina LA; Zaĭtseva NS; Krichevskaia GI; Ermakova NA; Tankovskiĭ VE; Kushnir VN; Kalamkarov GR; Shevchenko TF; Bykovskaia GN
    Vestn Oftalmol; 1996; 112(2):45-7. PubMed ID: 9045492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
    Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis.
    Kase S; Saito W; Ohno S; Ishida S
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5909-12. PubMed ID: 19516000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity of peripheral blood lymphocytes in diabetic retinopathy].
    Usov NI; Degtiarenko TV
    Oftalmol Zh; 1981; 36(5):284-7. PubMed ID: 6975452
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contents of T-lymphocytes and expression of intercellular adhesion molecule ICAM-1 in the retina and choroid in diabetic retinopathy].
    Zhaboedov GD; Skripnik RL; Sidorova MV
    Vestn Oftalmol; 2001; 117(5):41-3. PubMed ID: 11765468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the role of cytokines in different forms of eye diseases. 1. Tumor necrosis factor-alpha].
    Slepova OS; Gerasimenko VA; Makarov VP; Kushnir VN; Zakharova GIu; Bykovskaia GN; Vartanian IR; Sadrislamova LF
    Vestn Oftalmol; 1998; 114(3):28-32. PubMed ID: 9720396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot study.
    Hirata A; Takano A; Inomata Y; Yonemura N; Sagara N; Tanihara H
    Retina; 2007 Oct; 27(8):1074-8. PubMed ID: 18040248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation.
    Suchkov SV; Petrunin DD; Kostalevskaya AV; Kachkov IA; Elbeik T; Matsuura E; Paltsev MA
    Biomed Pharmacother; 2007 Jul; 61(6):323-37. PubMed ID: 17656060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of immunopathological and age factors in the pathogenesis of diabetic retinopathies].
    Kashintseva LT; Degtiarenko TV
    Oftalmol Zh; 1982; 37(1):17-21. PubMed ID: 6176926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immunity in patients with diabetes mellitus complicated by diabetic retinopathies].
    Danilova AI; Dekhtiareva OS
    Probl Endokrinol (Mosk); 1984; 30(5):29-34. PubMed ID: 6334294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus].
    Zhaboedov GD; Kopaenko AI
    Vestn Oftalmol; 2005; 121(6):29-31. PubMed ID: 16405060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders in the immune regulation and hemostasis as factors triggering the proliferative retinopathy in diabetes mellitus].
    Zaĭtseva NS; Balashova LM; Teplinskaia LE; Grishin VL; Gankovskaia LV
    Vestn Ross Akad Med Nauk; 2003; (5):28-32. PubMed ID: 12800486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.